Resiquimod-d6

SL-9835

Resiquimod-d₆, >98%

Related CAS No. : [144875-48-9] of the unlabelled compound

IUPAC Name : 2-((4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl)methyl)propan-1,1,1,3,3,3-d₆-2-ol

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a deuterium labelled version of Resiquimod, which is an immune response modifier that acts as a potent TLR 7/8 agonist. Resiquimod is used to treat viral skin lesions and certain types of skin cancer, such as early-stage cutaneous T-cell lymphoma (CTCL) and melanoma.

References : Hemmi H. et al.: Nat Immunol., 3(2), 196-200, 2002; Loré K. et al.: J. Immunol., 171(8), 4320-4328, 2003; Lee M. et al. Arch Pharm Res., 37(9), 1234-1240, 2014.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.